In The Legal's Intellectual Property supplement, read about how ADR can benefit IP cases, subject matter eligibility challenges and get some tips for securing patents for AI inventions.

Is a new method of diagnosing a disease patentable? Can it survive a motion to dismiss? And, irrespective of the current precedent, should a new method of diagnosing a disease be patentable?

 

The Attributes of ADR That Make It Advantageous for IP Cases

This article explores the factors that make mediation, and sometimes mediation in combination with arbitration, a good alternative to IP litigation and shows you how to get to the end of your client's dispute.

Allegations of willfulness inject the subjective intent of the accused infringer into the otherwise strict liability framework of patent infringement.

Since the U.S. Supreme Court's 2014 decision in Alice v. CLS Bank, which effectively put the brakes on securing software patents in the US, patent practitioners have been working to find ways to overcome the bar Alice established for satisfying the subject matter eligibility requirements of 35 U.S.C. Section 101.

While AI is rising as a key commercial player at the global scale with an expected market size of almost $400 billion by 2025, are patent laws around the world equipped to incentivize this revolution?

Along with cannabis, the Controlled Substances Act of 1970 designated many psychedelic compounds as Schedule I controlled substances.